Latest filing published 11 Dec 2018 for Tempest Therapeutics, Inc..
No signal scores available.
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This profile gathers the share dealings of Randall W. Whitcomb across 2 companies, led by INSMED Inc and Tempest Therapeutics, Inc. Over a trading history stretching from 31 March 2009 to 7 December 2018, the count stands at 13 filings.
The open-market record is one-sided, with 2 purchases worth €41k and not one sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 6 share grants and 5 option exercises.
The record was last updated on 11 December 2018 with a share grant in Tempest Therapeutics, Inc. The clock since the last published purchase (29 March 2011) now reads 5,687 days. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
13 of 13 declarations